Blueprint Genetics is a CLIA-certified (#99D2092375) laboratory and accredited by the College of American Pathologists (CAP #9257331) and by FINAS Finnish Accreditation Service, laboratory no. T292, accreditation requirement SFS-EN ISO 15189:2013. Detailed information about the scope is available on the FINAS website.

We offer genetic testing globally covering North and South America, Europe, Australia and the Middle East.

Please see more information about our quality control and accreditation through following link:

Quality control

* CLIA

– We are CLIA certified laboratory for high complexity testing approved by US authorities (Centers of Medicare & Medicaid Services – Clinical Laboratory Improvement Amendment Survey and Certificate Group) qualifying us to operate in following states or districts in USA: (Alabama, Alaska, American Samoa, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Guam, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virgin Islands (US), Virginia, Washington, West Virginia, Wisconsin, Wyoming).

Operations in North America

Our US facility in Seattle provides customer support, clinical genetics support, billing, and sample reception for our customers in South and North America. After receiving the samples, our office ships them with a secure courier service to our CLIA certified and CAP and ISO 15189 accredited facility in Helsinki, Finland. Our service model, which has been evaluated by US authorities for CLIA and CAP, ensures our ability to maintain our highest quality standards.

Important numbers

• NPI (National Provider Identifier): 1497133573
• EIN/Tax ID: 371768269